Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.

5-HT2C receptor Agonists Allosteric modulation Central nervous system disorders Drug discovery Ligand development Neurotherapeutics Pharmacological probes Positive allosteric modulators Signaling bias Target selectivity.

Journal

Current topics in medicinal chemistry
ISSN: 1873-4294
Titre abrégé: Curr Top Med Chem
Pays: United Arab Emirates
ID NLM: 101119673

Informations de publication

Date de publication:
2019
Historique:
received: 28 03 2019
revised: 14 05 2019
accepted: 16 05 2019
pubmed: 11 7 2019
medline: 29 10 2019
entrez: 11 7 2019
Statut: ppublish

Résumé

Serotonin (5-HT) 5-HT2C receptor (5-HT2CR) is recognized as a critical mediator of diseaserelated pathways and behaviors based upon actions in the central nervous system (CNS). Since 5-HT2CR is a class A G protein-coupled receptor (GPCR), drug discovery efforts have traditionally pursued the activation of the receptor through synthetic ligands with agonists proposed for the treatment of obesity, substance use disorders and impulse control disorders while antagonists may add value for the treatment of anxiety, depression and schizophrenia. The most significant agonist discovery to date is the FDAapproved anti-obesity medication lorcaserin. In recent years, efforts towards developing other mechanisms to enhance receptor function have resulted in the discovery of Positive Allosteric Modulators (PAMs) for the 5-HT2CR, with several molecule series now reported. The biological significance and context for signaling and function of the 5-HT2CR, and the current status of 5-HT2CR agonists and PAMs are discussed in this review.

Identifiants

pubmed: 31288724
pii: CTMC-EPUB-99490
doi: 10.2174/1568026619666190709101449
pmc: PMC6761005
mid: NIHMS1050909
doi:

Substances chimiques

Ligands 0
Receptor, Serotonin, 5-HT2C 0
Serotonin 5-HT2 Receptor Agonists 0
Serotonin 5-HT2 Receptor Antagonists 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1381-1398

Subventions

Organisme : NIDA NIH HHS
ID : F31 DA038922
Pays : United States
Organisme : NIDA NIH HHS
ID : F31 DA045511
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA038446
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007287
Pays : United States

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

Bioorg Med Chem Lett. 1999 Jan 18;9(2):265-70
pubmed: 10021942
Neuropharmacology. 1999 Apr;38(4):533-41
pubmed: 10221757
Neuroscience. 1999;91(2):587-97
pubmed: 10366016
J Clin Psychiatry. 1999 Jun;60(6):358-63
pubmed: 10401912
J Neurochem. 1999 Oct;73(4):1711-7
pubmed: 10501219
Biochem Pharmacol. 1999 Dec 1;58(11):1807-13
pubmed: 10571256
Mol Pharmacol. 2000 Jan;57(1):75-81
pubmed: 10617681
Synapse. 2000 Jun 1;36(3):205-21
pubmed: 10819900
RNA. 2000 May;6(5):755-67
pubmed: 10836796
J Pharmacol Exp Ther. 2000 Dec;295(3):1183-91
pubmed: 11082456
Neuroscience. 2001;103(1):111-6
pubmed: 11311791
J Pharmacol Exp Ther. 2001 Oct;299(1):332-42
pubmed: 11561096
Br J Pharmacol. 2001 Sep;134(2):386-92
pubmed: 11564657
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
Pharmacol Ther. 2001 Nov-Dec;92(2-3):179-212
pubmed: 11916537
Nat Rev Drug Discov. 2002 Mar;1(3):198-210
pubmed: 12120504
Neuropsychopharmacology. 2002 Oct;27(4):576-86
pubmed: 12377394
Biochimie. 2002 Aug;84(8):791-803
pubmed: 12457566
Mol Pharmacol. 2003 Jul;64(1):78-84
pubmed: 12815163
J Biol Chem. 2004 Jan 23;279(4):2945-54
pubmed: 14602721
Eur J Pharmacol. 2004 Jan 1;483(1):37-43
pubmed: 14709324
Pharmacol Ther. 2004 Feb;101(2):131-81
pubmed: 14761703
J Pharmacol Exp Ther. 2004 Sep;310(3):865-70
pubmed: 15113845
Psychopharmacology (Berl). 2004 Nov;176(3-4):376-85
pubmed: 15232674
Adv Appl Microbiol. 2004;56:121-54
pubmed: 15566978
J Pharmacol Exp Ther. 2005 May;313(2):862-9
pubmed: 15705738
J Neurochem. 2005 Jun;93(6):1603-15
pubmed: 15935077
Prog Nucleic Acid Res Mol Biol. 2005;79:299-338
pubmed: 16096031
J Pharmacol Exp Ther. 2006 Jun;317(3):1254-61
pubmed: 16517693
Chem Rev. 2006 Aug;106(8):3397-411
pubmed: 16895334
Neuropharmacology. 2007 Feb;52(2):279-90
pubmed: 16949622
Curr Top Med Chem. 2006;6(18):1971-85
pubmed: 17017968
Drug Metab Dispos. 2007 Jun;35(6):848-58
pubmed: 17344339
Neuroscience. 2007 Apr 25;146(1):286-97
pubmed: 17367945
Neuroscience. 2007 Jun 8;146(4):1677-88
pubmed: 17467185
Psychopharmacology (Berl). 2007 Dec;195(2):223-34
pubmed: 17673981
J Pharmacol Exp Ther. 2008 May;325(2):577-87
pubmed: 18252809
Biochem Biophys Res Commun. 2008 Jul 18;372(1):186-90
pubmed: 18477467
Pharmacol Ther. 2008 Jul;119(1):7-23
pubmed: 18554725
Behav Brain Res. 2008 Dec 16;195(1):198-213
pubmed: 18571247
Curr Opin Drug Discov Devel. 2008 Jul;11(4):438-45
pubmed: 18600561
ACS Chem Biol. 2008 Sep 19;3(9):530-41
pubmed: 18652471
Trends Pharmacol Sci. 2008 Sep;29(9):454-64
pubmed: 18676031
Prog Brain Res. 2008;172:319-46
pubmed: 18772040
Biochem Pharmacol. 2008 Nov 15;76(10):1276-87
pubmed: 18812172
J Lipid Res. 2009 Apr;50 Suppl:S237-42
pubmed: 19011112
Obesity (Silver Spring). 2009 Mar;17(3):494-503
pubmed: 19057523
Nat Rev Drug Discov. 2009 Jan;8(1):41-54
pubmed: 19116626
J Pharmacol Exp Ther. 2009 May;329(2):625-33
pubmed: 19225162
Psychopharmacology (Berl). 2009 Nov;207(1):119-25
pubmed: 19688201
Trends Pharmacol Sci. 2009 Sep;30(9):460-9
pubmed: 19729207
Int J Neuropsychopharmacol. 2010 Oct;13(9):1247-54
pubmed: 20663269
Crit Rev Biochem Mol Biol. 2010 Dec;45(6):555-66
pubmed: 20925600
Bioorg Med Chem Lett. 2011 Jan 1;21(1):34-7
pubmed: 21146986
Am J Drug Alcohol Abuse. 2011 Mar;37(2):117-22
pubmed: 21204739
J Pharmacol Exp Ther. 2011 Jun;337(3):673-80
pubmed: 21402690
Clin Pharmacol Ther. 2011 May;89(5):683-92
pubmed: 21412231
Neuropharmacology. 2011 Sep;61(3):513-23
pubmed: 21575646
PLoS One. 2011;6(6):e20508
pubmed: 21687728
Neurobiol Dis. 2012 Jan;45(1):8-13
pubmed: 21914481
Curr Protoc Pharmacol. 2010 Dec;Chapter 1:Unit 1.21
pubmed: 21935895
J Med Chem. 2012 Feb 23;55(4):1445-64
pubmed: 22148748
J Biol Chem. 2012 Mar 30;287(14):11049-59
pubmed: 22291020
J Pharmacol Exp Ther. 2012 May;341(2):424-34
pubmed: 22328576
BMC Neurosci. 2012 Mar 07;13:25
pubmed: 22397586
J Pharmacol Exp Ther. 2012 Sep;342(3):761-9
pubmed: 22685342
Neuropsychopharmacology. 2012 Oct;37(11):2505-14
pubmed: 22763621
ACS Chem Neurosci. 2012 Jul 18;3(7):538-45
pubmed: 22860223
J Biol Chem. 2013 Jan 4;288(1):181-91
pubmed: 23161547
Bioorg Med Chem Lett. 2013 Jan 1;23(1):330-5
pubmed: 23177783
Neuropsychopharmacology. 2013 May;38(6):957-67
pubmed: 23303047
ACS Chem Neurosci. 2013 Jan 16;4(1):110-21
pubmed: 23336050
J Neurosci. 2013 Jan 23;33(4):1615-30
pubmed: 23345234
Curr Top Med Chem. 2013;13(1):26-54
pubmed: 23409764
Drugs. 2013 Apr;73(5):463-73
pubmed: 23529825
Neuropsychopharmacology. 2013 Sep;38(10):1963-73
pubmed: 23632436
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3914-9
pubmed: 23683593
Neuropharmacology. 2014 Jan;76 Pt B:460-78
pubmed: 23850573
Nat Rev Drug Discov. 2013 Aug;12(8):630-44
pubmed: 23903222
Psychopharmacology (Berl). 2014 Jan;231(1):67-74
pubmed: 23925734
Neuropsychopharmacology. 2014 Jan;39(2):370-82
pubmed: 23939424
Nature. 2013 Nov 14;503(7475):295-9
pubmed: 24121438
Transl Psychiatry. 2014 Mar 11;4:e369
pubmed: 24618688
J Med Chem. 2014 Jun 26;57(12):5258-69
pubmed: 24878222
Perspect Medicin Chem. 2014 Jun 16;6:11-24
pubmed: 24963272
Mol Pharmacol. 2014 Nov;86(5):463-78
pubmed: 25061106
Nat Rev Drug Discov. 2014 Sep;13(9):692-708
pubmed: 25176435
Behav Brain Res. 2015 Jan 15;277:14-31
pubmed: 25217810
Synapse. 2015 Feb;69(2):78-85
pubmed: 25382408
Pharmacol Rev. 2015;67(1):176-97
pubmed: 25505168
Mol Pharmacol. 2015 Apr;87(4):660-73
pubmed: 25609374
J Med Chem. 2015 Feb 26;58(4):1992-2002
pubmed: 25633969
J Biol Chem. 2015 May 1;290(18):11537-46
pubmed: 25770211
ACS Med Chem Lett. 2015 Jan 20;6(3):329-33
pubmed: 25815155
Cell. 2015 Mar 26;161(1):133-145
pubmed: 25815991
J Biol Chem. 2015 May 15;290(20):12844-57
pubmed: 25825490
ACS Chem Neurosci. 2015 Jul 15;6(7):1071-88
pubmed: 25870913
ACS Chem Neurosci. 2015 Jul 15;6(7):1248-58
pubmed: 26120876
Annu Rev Psychol. 2016;67:23-50
pubmed: 26253543
Neuropharmacology. 2016 Feb;101:237-45
pubmed: 26427596
Pharmacol Ther. 2016 Jan;157:125-62
pubmed: 26617215
J Med Chem. 2016 Jan 28;59(2):578-91
pubmed: 26704965
Chem Rev. 2016 Jun 8;116(11):6707-41
pubmed: 26882314
ACS Chem Biol. 2016 May 20;11(5):1372-82
pubmed: 26900768
Neuroscience. 2016 Jun 2;324:50-61
pubmed: 26926963
Austin J Pharmacol Ther. 2014;2(1):null
pubmed: 27148592
J Pharmacol Exp Ther. 2016 Jul;358(1):39-49
pubmed: 27189964
Cereb Cortex. 2017 Jun 1;27(6):3125-3139
pubmed: 27252352
Diabetes. 2016 Oct;65(10):2943-53
pubmed: 27385157
Biol Psychiatry. 2017 May 1;81(9):737-747
pubmed: 27516377
Clin Obes. 2016 Oct;6(5):285-95
pubmed: 27627785
Nicotine Tob Res. 2017 Aug 1;19(8):944-951
pubmed: 27815511
Drug Alcohol Depend. 2017 Mar 01;172:21-33
pubmed: 28107679
ACS Chem Neurosci. 2017 May 17;8(5):1065-1073
pubmed: 28107783
J Biochem Mol Toxicol. 2017 Jun;31(6):null
pubmed: 28186389
J Biol Chem. 2017 Apr 14;292(15):6352-6368
pubmed: 28258217
Neuron. 2017 May 3;94(3):431-446
pubmed: 28472649
J Med Chem. 2017 Jul 27;60(14):6166-6190
pubmed: 28635286
J Med Chem. 2017 Jul 27;60(14):6273-6288
pubmed: 28657744
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
J Med Chem. 2017 Dec 14;60(23):9575-9584
pubmed: 29116785
Neuropsychopharmacology. 2018 Jan;43(1):220-221
pubmed: 29192668
Cell. 2018 Feb 8;172(4):719-730.e14
pubmed: 29398112
J Med Chem. 2019 Jan 10;62(1):288-305
pubmed: 29620897
J Med Chem. 2019 Jan 10;62(1):88-127
pubmed: 30106578
PLoS One. 2018 Aug 29;13(8):e0203137
pubmed: 30157263
Neuropsychopharmacology. 2019 Jan;44(1):230-231
pubmed: 30202047
Curr Top Med Chem. 2018;18(23):2002-2006
pubmed: 30621563
Eur J Med Chem. 2019 Feb 15;164:499-516
pubmed: 30622024
ACS Chem Neurosci. 2019 Jul 17;10(7):3241-3248
pubmed: 30645940
Eur J Pharmacol. 2019 Apr 5;848:131-139
pubmed: 30689993
Nature. 1995 Apr 6;374(6522):542-6
pubmed: 7700379
J Pharmacol Exp Ther. 1994 Oct;271(1):83-90
pubmed: 7965760
Psychopharmacology (Berl). 1995 Aug;120(4):384-91
pubmed: 8539318
Arch Biochem Biophys. 1996 Jun 15;330(2):430-4
pubmed: 8660675
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8078-82
pubmed: 8755606
Biochem Mol Biol Int. 1996 Nov;40(5):931-8
pubmed: 8955882
Pharmacol Biochem Behav. 1997 Jan;56(1):41-6
pubmed: 8981607
J Pharmacol Exp Ther. 1997 Aug;282(2):747-59
pubmed: 9262338
N Engl J Med. 1997 Aug 28;337(9):581-8
pubmed: 9271479
J Med Chem. 1997 Aug 15;40(17):2762-9
pubmed: 9276022
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14115-9
pubmed: 9391162
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4102-7
pubmed: 9539697
Mol Pharmacol. 1998 Jul;54(1):94-104
pubmed: 9658194
Pharmacol Ther. 1998 Sep;79(3):231-57
pubmed: 9776378

Auteurs

Eric A Wold (EA)

Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States.

Christopher T Wild (CT)

Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States.

Kathryn A Cunningham (KA)

Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States.

Jia Zhou (J)

Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH